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The rapid transition in economic development, 
industrialization, and globalization has led to lifestyle 
changes and increased life expectancy in most countries. 
This increase in lifestyle and cultural changes, including 
unhealthy dietary habits and a decrease in physical 
activity, has been accompanied by an increase in the 
prevalence of non-communicable (chronic) diseases, 
including diabetes mellitus (DM). In Indonesia, the 
number of type 2 diabetes mellitus (T2DM) patients has 
increased rapidly, not only in urban but also in rural 
areas1, making Indonesia one of the countries with the 
most T2D cases in the world2. 
In 2017, the International Diabetes Federation (IDF)2 
reported that 10.3 million T2DM patients lived in 
Indonesia, which had increased to 10.7 million in 2019. 
Meanwhile, in the Special Region of Yogyakarta (Daerah 
Istimewa Yogyakarta, DIY), according to the Health Center 
Integrated Disease Survey report in 2016, DM, with 9,473 
cases, was in the fourth position of the top 10 diseases in 
DIY. An examination of preventable lifestyle-related risk 
factors of T2DM identified overweight, abdominal 
obesity, sedentary lifestyle with high saturated fat, 
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 Abstract 
The number of people with type 2 diabetes mellitus (T2DM) in 
Indonesia increases every year. Control of the development of T2DM 
can be done by screening using Finnish Diabetic Risk Score 
(FINDRISC)-Indonesian. FINDRISC is a valid tool for estimating the 
risk of T2DM within the next 10 years. This condition can have a major 
impact on the estimated life span and quality of life in the future. The 
purpose of this research is to determine the relationship between 
FINDRISC-Indonesian and respondent characteristics with HRQoL 
from EuroQol-5 Dimension-5 Level (EQ-5D-5L) in Yogyakarta. The 
cross-sectional study was conducted on 125 respondents who met the 
inclusion criteria. The risk of developing T2DM was assessed using a 
validated and widely used FINDRISC (range 0-26 points), and quality 
of life was measured by the EQ-5D-5L instrument. Overall data were 
analyzed using the Pearson correlation test and Independent t-test. 
The results showed the domain of pain was the domain that reported 
most respondents' most problems (28.8%). The respondent's utility 
value was 0.958 ± 0.69, and the VAS value was 79.4 ± 0.7. There was a 
significant difference in utility value based on age characteristics (p = 
0.013). There is a relationship between age and utility value (p = 0.006) 
and FINDRISC score with utility value (p = 0.003). This study 
concludes that a high FINDRISC score affects the quality of life, and 
older age has a lower quality of life. 
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refined carbohydrate, total energy, and low dietary fiber 
intake3. 
Unhealthy lifestyle habits, such as poor diet and lack of 
physical activity, are among the leading causes of 
mortality and disability in the western world4. Among 
DM cases, more than 90% of patients have T2DM, and 
over 50% of cases are undetected5. Diabetes mellitus risk 
score is a straightforward, less time-consuming, non-
invasive, and cost-effective approach to assess an 
individual’s risk of undiagnosed T2DM and 
dysglycaemia6. Although the preference-based Health-
Related Quality of Life (HRQoL) effects of T2DM have 
been examined previously7, the association between 
estimated diabetes risk and HRQoL is less understood. A 
few previous studies have reported an association 
between the estimated T2DM risk and HRQoL.  
In this study, we have used Finnish Diabetic Risk Score 
(FINDRISC), one of the most frequently used 
instruments for assessing DM’s risk8. Several non-
invasive screening questionnaires for assessing the risk of 
T2DM have been developed in the past ten years, like 
FINDRISC and CANRISK (The Canadian Diabetes Risk 
Questionnaire). Compared to invasive tools, FINDRISC 
provides a feasible method to routinely screen the 
population to detect individuals with either undetected 
T2DM, abnormal glucose metabolism, or elevated risk to 
develop T2DM in the future. Although most T2DM risk 
questionnaires share similar characteristics and 
constructs, FINDRISC is currently one of the most widely 
validated and utilized T2DM risk scores9. FINDRISC 
assesses whether an individual has undiagnosed T2DM 
or dysglycaemia or the probability of developing T2DM 
during the following ten years10. The Indonesian version 
of the FINDRISC questionnaire has been validated, and 
the results are valid and reliable so that it can be used as a 
screening tool for T2DM in Indonesia11. 
The previous study in Finland showed that low HRQoL 
was significantly and directly associated with the 
estimated risk of developing T2DM; the instruments 
used to measure the quality of life were 15D and SF-6D. 
Old age, lack of physical activity, obesity, and high blood 
glucose history were the FINDRISC factors most 
prominently associated with lower HRQoL12. FINDRISC 
was initially developed to assess future T2DM risk, 
subsequent studies have shown that it can also be used to 
detect prevalent abnormal glucose metabolism13 and 
predict other significant health outcomes, such as 
coronary heart disease, stroke, and overall mortality14.  
Previously, no one had researched the relationship 
between the risk of T2DM and the quality of life in 
Yogyakarta, so this research was conducted in 
Yogyakarta, which has the second-highest number of 
DM cases in Indonesia. Since FINDRISC is a feasible tool 
for estimating a patient’s T2DM risk in routine clinical 
practice, it could provide a simple way to evaluate a 
patient’s HRQoL in clinical work and research. The use 
of additional separate HRQoL questionnaires would not 
be feasible12. This research has two objectives. First, to 
determine the relationship between respondent 
characteristics and utility. Second, to measure how 
HRQoL can be associated with T2DM risk estimates by 
examining the FINDRISC score and utility relationship. 
 
MATERIALS AND METHODS 
Research design and participants 
This research was an observational study conducted 
prospectively with a cross-sectional study design 
conducted in April-November 2019. Observations were 
made on respondents who were not diagnosed with 
T2DM in Yogyakarta. The sampling targets include the 
academic community, cleaning service, and security 
guards at Universitas Ahmad Dahlan; the members of 
the Yogyakarta City Family Welfare Empowerment 
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(Pemberdayaan Kesejahteraan Keluarga; PKK), the residents 
of the Cepoko Indah Bantul housing estate, and the 
employees of the Gunung Kidul Regional Development 
Planning Agency (Badan Perencanaan Pembangunan 
Daerah; Bappeda) office. The sampling technique in this 
research was consecutive sampling according to 
inclusion and exclusion criteria. The number of samples 
in this study was calculated based on the formula from 
Lemeshow et al.15 with the population of Yogyakarta who 
was not diagnosed with T2DM as much as 3,558,865; the 
number of samples obtained 96 respondents. A larger 
number of samples will produce representative results, 
so this study took the number of samples as many as 125 
respondents. Before conducting the study, respondents 
signed the informed consent form, then were 
interviewed to obtain demographic data, FINDRISC 
scores, and quality of life. This research has been 
approved by the Ethics Commission of the Faculty of 
Dentistry, Universitas Gadjah Mada, with No. 
0095/KKEP/FKG-UGM/EC/2019. 
Research instruments 
The instruments used in this study were the Indonesian 
version of the FINDRISC, the EuroQoL-5 Dimension-5 
Level (EQ-5D-5L), and the Indonesian version of the 
Visual Analog Scale (VAS). Risk score for T2DM: The 
instrument used to measure the risk score for T2DM was 
the Indonesian version of the FINDRISC, which was 
previously validated11. The questions in FINDRISC 
including age, body mass index (BMI), waist 
circumference, daily physical activity, consumption of 
vegetables/fruit, history of consumption of 
antihypertensives, history of high blood sugar levels, and 
family history of T2DM. Categorical response options 
were weighted (higher levels indicate significance larger) 
and summed to get a total risk score. Total scores ranged 
from 0 to 26, in which higher scores correspond to a 
greater risk of diabetes. The FINDRISC scores were 
categorized into less than 7 (low, estimated 1-100 
developing disease), 7-11 (slightly elevated, estimated 1 
in 25 develops disease), 12-14 (moderate, estimated 1 in 6 
develops disease), 15-20 (high, estimated 1 in 3 develops 
the disease) and more than 20 (very high, estimated 1 in 
2 develops the disease)12. 
The questionnaire used to measure respondent’s utility 
was the EQ-5D-5L and the VAS. The EQ-5D-5L 
questionnaire was a generic instrument with higher 
scores representing better health status consisting of five 
dimensions: mobility, self-care, daily activities, pain or 
discomfort, and anxiety or depression. Each dimension 
had five levels consist of level 1 (no problem), level 2 
(slight or minor problematic), level 3 (moderate 
problematic), level 4 (severe problematic), and level 5 
(unable or extreme problematic). General health status 
was measured by VAS with a value of 1-100, in which 0 
was the worst health status, and 100 was the best health 
status. The EQ-5D-5L questionnaire used in this study 
was a validated standard Indonesian version 1.0 
questionnaire with a population of Indonesians. This 
study's quality of life score was calculated using the 
Indonesian version of the EQ-5D-5L value set developed 
with the Indonesian population16. 
Data analysis 
Analyses were performed using Statistical Package for 
the Social Science (SPSS) software version 23. Respondent 
characteristics data such as age, gender, occupation, 
income, BMI, waist circumference, physical activity, daily 
fruit/vegetable consumption, history of 
antihypertensive use, history of high blood sugar levels, 
and family history of diabetes were described 
descriptively in terms of means with Standard Deviation 
(SD). Analysis of the relationship between respondents' 
characteristics (gender, education, and occupation) with 
utility was examined using the Spearman correlation test. 
Meanwhile, to see the relationship between age and the 
Wahyuningtyas NS, Perwitasari DA, Satibi. 2021. Relationship Between FINDRISC with Health-Related Quality of Life in Yogyakarta 
71 
FINDRISC score with utility was examined using the 
Pearson correlation test. 
 
RESULTS AND DISCUSSION 
Demographic characteristic 
Characteristics of respondents in this study including 
age, gender, education, income, and occupation, while 
the characteristics of respondents based on FINDRISC 
consisted of age, BMI, waist circumference, daily physical 
activity, daily consumption of vegetables/fruit, history 
use of antihypertensives, history of high blood sugar 
levels and family history of diabetes. As presented in 
Table I, respondents aged <45 years (45.6%), 45-54 years 
were 34 (27.2%), 55-64 years 28 (22.4%) and 6 years older 
than 64 (4.8%). Respondents in this study were more 
dominated by respondents aged >45 years. This was 
because the research targets were prioritized on 
respondents aged >45 years, where a person was more at 
risk of developing T2DM at >45 years of age, had a family 
history of having T2DM, and being overweight or obese. 
Previous research stated that individuals with obesity 
based on waist circumference and aged ≥50 years could 
increase the risk of T2DM17. Asymptomatic children or 
adolescents who were obese and had two risk factors, for 
example, a first-generation family history of T2DM 
(mother/father/older sibling), should be screened. It 
further recommends that screening be started at the age 
of 10 (or the onset of puberty if puberty occurs at a 
younger age) and that screening was repeated every 
three years18. 
The average BMI of respondents in this study was 25.35 
± 4.16 kg/m2, so it could be seen that the average BMI of 
the respondents in this study was included in the 
overweight category. The BMI was divided into three 
categories consist of <25 kg/m2 (normal), 25-30 kg/m2 
(overweight), and >30 kg/m2 (obese). Respondents who 
had normal BMI were 48.8%, overweight 28.8%, and 
obese 12%. Being overweight was an important predictor 
of T2DM, known as "diabetes"19. 
Weight gain between the ages of 25-40 years results in the 
early onset of T2DM; the age difference at diagnosis of 
T2DM for individuals who had stable weight compared 
to severe weight gain was five years for men and three 
years for women20. The average waist circumference of 
the respondents was 93.41±11.43 cm. In this study, the 
waist circumference for men and women was divided 
into three categories. Women's waist circumference 
consists of <80 cm, 80-88 cm, and >88 cm, while for men 
consists of <94 cm, 94-102 cm, and >102 cm.  
Determining BMI and waist circumference were 
important to estimate the risk of T2DM, especially for 
those who had low or normal body weight because these 
two parameters affect T2DM. Using BMI or waist 
circumference alone will lead to an inadequate 
assessment of the risk of T2DM. The BMI and waist 
circumference serve as parameters for estimating general 
or abdomen fat mass. It was assumed that abdominal fat 
mass was crucial in the development of T2DM and other 
chronic diseases such as cardiovascular disease and 
cancer21. 
Maintenance of physical activity is an important focus for 
blood glucose management and health in individuals 
with diabetes and prediabetes. Exercise could improve 
blood glucose control in individuals with T2DM, reduce 
cardiovascular risk factors, contribute to weight loss and 
improve well-being22. Regular exercise could prevent or 
delay the development of T2DM23. As much as 59 (47.2%) 
of the 125 respondents did not routinely perform 
physical activity <30 minutes per day. Structured lifestyle 
interventions that include physical activity performed for 
150-175 minutes/week and dietary energy restriction 
targeting 5% -7% weight loss had shown a 40%-70% 
reduction in the risk of developing T2DM in individuals 
with intolerance disorders.  
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Prehypertension and hypertension were independently 
and strongly associated with T2DM.  The risk of diabetes 
incidence was significantly greater in individuals whose 
blood pressure was not well controlled than those who 
were well controlled24. Respondents who regularly 
consume antihypertensives such as ACE inhibitors were 
15 (12%). Although the clinical impact of blood pressure 
requires further analysis, active control of blood pressure 
in normal-prehypertensive individuals should be 
considered to prevent the development of T2DM. The 
pathophysiological mechanism that explains 
hypertension and T2DM was unclear, but several 
hypotheses had been proposed. High blood pressure had 
been shown to induce microvascular dysfunction, which 
may contribute to the pathophysiology of the 
development of T2DM closely related to hypertension, 
and biomarkers of endothelial dysfunction were 
predictors of T2DM independently25. 
Before reaching T2DM status, a person with insulin 
resistance would reach the prediabetes stage, or we 
usually call Impaired Glucose Tolerance (IGT) and 
Impaired Fasting Glucose (IFG). Prediabetes was a 
serious health condition where blood sugar levels were 
higher than normal but not high enough to be diagnosed 
as diabetes. In this study, 10 (8%) respondents had a 
history of high blood sugar levels. Prediabetes was 
associated with dysglycemia, central obesity, 
inflammation, and endothelial dysfunction. Oxidative 
stress contributes to the pathogenesis of cardiovascular 
disease26.  
Many antioxidant markers such as thiol/disulfide 
homeostasis, which had many cellular activities such as 
protection against antioxidants, detoxification, cell 
growth, and apoptosis, could be associated with 
triglyceride levels in early preclinical atherosclerosis, 
especially when plasma blood sugar levels were 
elevated27. If a person had been declared to had 
prediabetes, precautions must be taken immediately to 
prevent the development of prediabetes into DM. 
Lifestyle intervention programs modify modifiable risk 
factors for prediabetes and diabetes by targeting obesity 
with increased physical activity and dietary changes. 
Family history with T2DM was associated with various 
metabolic disorders and a strong risk factor for the 
development of T2DM28. A total of 41 (32.8%) 
respondents had a first-degree family history with 
diabetes, and 14 (11.2%) respondents had a second-
degree family history with diabetes. As many as 92 
(73.6%) respondents in this study were full and part-time 
workers, consisting of lecturers, civil servants, 
government/private employees, security guards, as well 
as cleaning services. Respondents who retirees were 8 
(6.4%) and 25 (20%) of respondents were not working. 
The respondents' education level varied, and 68 (54.4%) 
respondents had an income of >Rp. 2,000,000,-. The 
results of measuring diabetes risk scores using 
FINDRISC showed that 52 (41.6%) respondents had a 
fairly low score (7-11). The study sample characteristic 
was described in relation to FINDRISC categories in 
Table II. The average (SD) and median (range) 
FINDRISC scores were 8.136 (4.3) and 8 (1 to 17), 
respectively. 
Description of the quality of life 
The EQ-5D-5L questionnaire consisted of five domains; 
mobility, self-care, daily activities, pain/ discomfort, and 
anxiety/depression. These dimensions had five levels; no 
problem, slight/minor problems, moderate problems, 
severe problems, and unable/extreme problems. Table 
III provides an overview of the percentage distribution of 
respondents based on each EQ-5D domain level. Based 
on Table III, it could be seen that the mobility domain of 
0.8%(n=1) of respondents had severe problems, 
3.2%(n=4) had a minor problem, and 96%(n=120) had no 
problems. For the self-care domain, there were no 
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respondents who complained about problems (100%, 
n=125). In the domain of daily activities that were usually 
carried out, there were 0.8% (n=1) of respondents who 
complained about slight problems, and as many as 
99.2%(n=124) of respondents admitted that there were no 
problems in their daily activities. In the pain/discomfort 
domain, 4%(n=5) of respondents complained of 
moderate problems, 24.8%(n=31) had a slight problem, 
and 79.2%(n=99) of respondents had no problems.  
Table I. Characteristics research respondents 
Respondents characteristic (n=125) n % 
Aged (year) 
 < 45 years 57 45.6 
45-54 years 34 27.2 
55-64 years 28 28 
Older than 64 years  6 4.8 
Gender  
Male  63 50.4 
Female  62 49.6 
Body Mass Index  
x̄ ± SD (25.35±4.16) kg/m2  
 <25 kg/m2  61 48.8 
25-30 kg/m2  49 39.2 
 >30 kg/m2  15 12 
Waist circumference  
x̄ ± SD (93.41±11.43) cm 
 <94 cm (men)/<80 cm (women) 38 30.4 
94-102 cm (men)/80-88 cm (women)  36 28.8 
 >102 cm (men)/>88 (women) 51 40.8 
Less than 30 minutes of daily physical activity  59 47.2 
More than 30 minutes of daily physical activity  66 52.8 
History of blood pressure medication  15 12 
No history of blood pressure medication 110 88 
History of high blood glucose  10 8 
No history of high blood glucose  115 92 
Family diabetes  
No history of family diabetes  70 56 
1st degree relative  41 32.8 
2nd degree relative  14 11.2 
Occupation  
Employed Full time/Part time 92 73.6 
Retired 8 6.4 
Unemployed or on disability pension  25 20 
Education  
Elementary/Junior High 23 18.4 
Senior High 37 29.6 
Diploma/Bachelor 38 30.4 
Master 27 21.6 
Income (Rp)   
≤2.000.000 37 29.6 
>2.000,000 68 54.4 
Unknown/Have no income 20 16 
 
Table II. The characteristics of the respondents across the 
FINDRISC categories 
Variable 
Finnish Diabetes Risk Score 
<7 7-11 12-14 15-20 >20 
(n= 46) (n=52) (n=13) (=14) (n=0) 
Age 
<45 years 26 (56.5) 24 (46.1) 5 (38.4) 2 (14.2) 0 (0.0) 
45 to 54 years  14 (30.4) 12 (23) 4 (30.7) 4 (28.5) 0 (0.0) 
55 to 64 years  5 (10.8) 15 (28.8) 4 (30.7) 4 (28.5) 0 (0.0) 
>64 years  1 (2.1) 1 (1.9) 0 (0.0) 4 (28.5) 0 (0.0) 
BMI 
<25 kg/m2   32 (69.5) 21 (40.3) 4 (30.7) 3 (21.4) 0 (0.0) 
25-30 kg/m2   14 (30.4) 27 (51.9) 4 (30.7) 5 (35.7) 0 (0.0) 
>30 kg/m2  0 (0.0) 24 (46.1) 5 (38.4) 6 (42.8) 0 (0.0) 




27 (58.6) 11 (21.1) 0 (0.0) 0 (0.0) 0 (0.0) 
94-102 cm 
(men)/80-88 
cm (women)  




5 (10.8) 23 (44.2) 12 (92.3) 13 (92.8) 0 (0.0) 












0 (0.0) 3 (5.7) 2 (15.3) 5 (35.7) 0 (0.0) 
Family diabetes  
No history of 
family diabetes 
41 (89) 25 (48) 1 (7.7) 2 (14.2) 0 (0.0) 
2nd degree 
relative  
3 (6.5) 9 (17.3) 1 (7.7) 1 (7.1) 0 (0.0) 
1st degree 
relative   
2 (4.3) 18 (34.6) 11 (84.6) 11 (78.5) 0 (0.0) 
 
Table III. Distribution of respondents based on quality of life 
in each domain and level 
Domain 































































Mobility 96 3.2 0 0.8 0 
Selfcare 100 0 0 0 0 
Daily activities 99.2 0.8 0 0 0 
Pain/discomfort 79.2 24.8 4 0 0 
Anxiety/depression 89.6 8.8 1.6 0 0 
 
For the anxiety/depression domain, there were 1.6% 
(n=2) of respondents complained of moderate problems, 
8.8% (n=11) of respondents complained about slight 
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problems, and as many as 89.6% (n=112) of respondents 
did not complain about a problem. It could be concluded 
that for level 2 (slight problems), the domain that most 
respondents complained about was the pain/discomfort 
domain, which was 24.8%(n=31), the anxiety/depression 
domain was 8.8% (n=11) respondents, the mobility 
domain was 3,2% (n=4) of respondents, and the last was 
the activity domain that was carried out by 0.8% (n=1). 
The average value of the respondent’s utility and VAS in 
this study could be seen in Table IV. The utility value of 
the respondents was 0.958±0.69, while the VAS value 
obtained was 79.04±0.71. The average utility value in this 
study population of Indonesians was 0.9116. Compared 
with the utility value of T2DM patients, it was very 
different; the utility values of T2DM patients that had 
been studied previously were 0.7529 and 0.777. 
Table IV. The value of the respondent’s utility 




The relationship between respondent characteristics and 
quality of life 
The relationship between respondent characteristics and 
quality of life could be seen in Table V. The results of the 
analysis between respondents and utility characteristics 
found that age influenced the HRQoL of the respondents 
who participated in this study (p-value = 0.006, <0.05). 
The correlation coefficient value indicating the level of 
correlation between age and utility was -0.246. The 
correlation between age and utility was weak and 
negative; older respondents had a lower utility value. The 
ages of the respondents who participated in this study 
were very diverse, the lowest age was 18 years, and the 
highest age was 68 years. Complaints of illness or 
discomfort caused respondents' low utility value whose 
age was higher; most often, it was a pain in the joints. 
Other characteristics of respondents such as gender, 
education level, and occupation show a significance 
value >0.05, which indicates that in this study, gender, 
education level, and occupation had no relationship with 
HRQoL or not affects the HRQoL value of respondents. 











Age -0.246 0.006* 
Education -0.046 0.61 
Job -0.142 0.113 
* : <0.05 
 
Relationship between FINDRISC and HRQoL 
The main objective of this study was to see the 
relationship between FINDRISC and HRQoL. Previous 
research had shown an association between low quality 
of life (QoL) and an increased risk of T2DM12. The 
following was the Pearson test table between the 
FINDRISC score and HRQoL. Table VI shows the 
Pearson correlation test results between the FINDRISC 
and the utility value, the results above indicate that the 
significance value obtained was 0.003 (p <0.05). It could 
be concluded that the FINDRISC score with the HRQoL 
had a relationship in this study. 
The correlation between the two variables could be seen 
from the Pearson correlation value, where the result was 
-0.265. The correlation between the FINDRISC score and 
the utility value was weak and had a negative correlation. 
In this study, there was no relationship between the 
FINDRISC score and the VAS value where the p-value 
was >0.05. An oral glucose tolerance test (OGTT) was a 
valid tool for describing a patient’s current glucose 
metabolism status. A self-reported history of high blood 
glucose may indicate ongoing glucose metabolism 
problems and reflect the individual’s worry about their 
health and wellbeing. 








FINDRISC Utility -0.265 0.03* 
FINDRISC VAS  -0.166 0.65 
* : <0.05 
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The FINDRISC is a non-invasive comprehensive tool that 
can be used to estimate the risk of T2DM and other 
glucose metabolism disorders13 and morbidity and total 
mortality30. Previous research has shown that lifestyle 
interventions could effectively prevent the onset of 
T2DM31 in respondents with glucose intolerance 
disorders, especially in respondents with high 
FINDRISC scores32.  
The present study had strengths and potential 
weaknesses. First, the application of a widely used and 
validated instrument for diabetes risk and HRQoL. 
Second, consideration of the potential HRQoL effects of 
socioeconomic factors. A shortcoming to this study was 
the cross-sectional setting that did not allow examining 
changes in HRQoL over time in people with varying 
FINDRISC scores. This study was attended by 
respondents of various ages, ranging from young, 
middle-aged, and older individuals from Yogyakarta. 
Diabetes screening from a young age effectively prevents 




This study found that age and FINDRISC score were 
negatively related to quality of life, where the higher the 
age and the FINDRISC score, the lower the respondent's 
quality of life. 
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